These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

36 related items for PubMed ID: 2849661

  • 1. Platelet-generated thromboxane A2 enhances norepinephrine release from adrenergic nerves.
    Trachte GJ, Stein E.
    J Pharmacol Exp Ther; 1988 Dec; 247(3):1139-45. PubMed ID: 2849661
    [Abstract] [Full Text] [Related]

  • 2. Thromboxane A2 augments adrenergic neurotransmission.
    Stein E, Trachte GJ.
    Eicosanoids; 1990 Dec; 3(4):205-11. PubMed ID: 1963539
    [Abstract] [Full Text] [Related]

  • 3. An antithrombotic agent, NQ301, inhibits thromboxane A2 receptor and synthase activity in rabbit platelets.
    Jin YR, Cho MR, Lee KS, Lee JJ, Lim Y, Han XH, Oh KW, Hong JT, Yoo HS, Yun YP.
    Basic Clin Pharmacol Toxicol; 2005 Sep; 97(3):162-7. PubMed ID: 16128910
    [Abstract] [Full Text] [Related]

  • 4. Neuropeptide Y-induced potentiation of noradrenergic vasoconstriction in the human saphenous vein: involvement of endothelium generated thromboxane.
    Fabi F, Argiolas L, Ruvolo G, del Basso P.
    Br J Pharmacol; 1998 May; 124(1):101-10. PubMed ID: 9630349
    [Abstract] [Full Text] [Related]

  • 5. Thromboxane mimetics enhance adrenergic neurotransmission in the rabbit-isolated portal vein.
    Stein EA, Trachte GJ.
    J Cardiovasc Pharmacol; 1989 Sep; 14(3):469-74. PubMed ID: 2476628
    [Abstract] [Full Text] [Related]

  • 6. Acetylcholine-induced contractions in isolated rabbit pulmonary arteries: role of thromboxane A2.
    Altiere RJ, Kiritsy-Roy JA, Catravas JD.
    J Pharmacol Exp Ther; 1986 Feb; 236(2):535-41. PubMed ID: 3080588
    [Abstract] [Full Text] [Related]

  • 7. Physiological concentrations of epinephrine potentiate thromboxane A2 release from platelets in the isolated rat heart.
    Purchase M, Dusting GJ, Li DM, Read MA.
    Circ Res; 1986 Jan; 58(1):172-6. PubMed ID: 3080260
    [Abstract] [Full Text] [Related]

  • 8. Acetyl glycerylphosphorylcholine aggregates human platelets through two distinct pathways, both dependent on arachidonic acid metabolism.
    Macconi D, Morzenti G, Livio M, Morelli C, Cassina G, Remuzzi G.
    Lab Invest; 1985 Feb; 52(2):159-68. PubMed ID: 3155816
    [Abstract] [Full Text] [Related]

  • 9. A major role of ADP in thromboxane transfer experiments: studies in patients with platelet secretion defects.
    Rao AK, Willis J, Holmsen H.
    J Lab Clin Med; 1984 Jul; 104(1):116-26. PubMed ID: 6429260
    [Abstract] [Full Text] [Related]

  • 10. 5-Hydroxytryptamine(1A) receptor activation enhances norepinephrine release from nerves in the rabbit saphenous vein.
    Cohen ML, Schenck KW, Hemrick-Luecke SH.
    J Pharmacol Exp Ther; 1999 Sep; 290(3):1195-201. PubMed ID: 10454495
    [Abstract] [Full Text] [Related]

  • 11. Thromboxane receptor agonists enhance adrenergic neurotransmission in rabbit isolated mesenteric arteries.
    Trachte GJ, Stein EA.
    J Pharmacol Exp Ther; 1989 Apr; 249(1):216-20. PubMed ID: 2540313
    [Abstract] [Full Text] [Related]

  • 12. Thromboxane synthase inhibitors suppress more effectively the aggregation of thromboxane receptor-desensitized than that of normal platelets: role of adenylylcyclase up-regulation.
    Vezza R, Nenci GG, Gresele P.
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1497-505. PubMed ID: 8531121
    [Abstract] [Full Text] [Related]

  • 13. Antiplatelet activity of J78 (2-Chloro-3-[2'-bromo, 4'-fluoro-phenyl]-amino-8-hydroxy-1,4-naphthoquinone), an antithrombotic agent, is mediated by thromboxane (TX) A2 receptor blockade with TXA2 synthase inhibition and suppression of cytosolic Ca2+ mobilization.
    Jin YR, Cho MR, Ryu CK, Chung JH, Yuk DY, Hong JT, Lee KS, Lee JJ, Lee MY, Lim Y, Yun YP.
    J Pharmacol Exp Ther; 2005 Jan; 312(1):214-9. PubMed ID: 15328379
    [Abstract] [Full Text] [Related]

  • 14. Platelet reactivity in vitro in relation to thromboxane in healthy pregnancy.
    Horn EH, Hardy E, Cooper J, Heptinstall S, Rubin PC.
    Thromb Haemost; 1996 Feb; 75(2):346-51. PubMed ID: 8815588
    [Abstract] [Full Text] [Related]

  • 15. Effects of etamsylate on platelet functions and arachidonic acid metabolism.
    Okuma M, Takayama H, Sugiyama T, Sensaki S, Uchino H.
    Thromb Haemost; 1982 Dec 27; 48(3):330-3. PubMed ID: 6819650
    [Abstract] [Full Text] [Related]

  • 16. Mepacrine blockade of arachidonate-induced washed platelet aggregation: relationship to mepacrine inhibition of platelet cyclooxygenase.
    Raz A.
    Thromb Haemost; 1983 Dec 30; 50(4):784-6. PubMed ID: 6420923
    [Abstract] [Full Text] [Related]

  • 17. Influence of trapidil derivatives on arachidonic acid- and prostaglandin endoperoxide analogue- induced platelet aggregation and thromboxane A2 formation.
    Heinroth I, Block HU, Mest HJ.
    Biomed Biochim Acta; 1984 Dec 30; 43(8-9):S389-92. PubMed ID: 6440555
    [Abstract] [Full Text] [Related]

  • 18. [The modification of the biosynthesis and effect of thromboxane A2 and prostacyclin by trapidil (Rocornal)].
    Block HU, Heinroth I, Giessler C, Pönicke K, Mentz P, Zehl U, Rettkowski W, Dunemann A, Förster W.
    Biomed Biochim Acta; 1983 Dec 30; 42(2-3):283-99. PubMed ID: 6411078
    [Abstract] [Full Text] [Related]

  • 19. Possible generation of potent vasocontracting substance from prostaglandin endoperoxide analogs, human platelets mixture.
    Shibata S, Ho WK, Ishida U.
    J Pharmacol Exp Ther; 1980 Nov 30; 215(2):357-62. PubMed ID: 7441499
    [Abstract] [Full Text] [Related]

  • 20. Thromboxane synthesis and actions in isolated adrenergic nerve (pheochromocytoma-12) cells.
    Trachte GJ, Hook PJ, Kemp JR, Acosta EP, Ziegler RJ.
    J Pharmacol Exp Ther; 1988 Oct 30; 247(1):43-6. PubMed ID: 3139869
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 2.